Esophageal Cancer from Detection to Treatment
What Is Esophageal Cancer?
Esophageal cancer begins in the esophagus, the long tube that carries food from the throat to the stomach.
The two main types are:
Adenocarcinoma
starts in the lower part of the esophagus, often linked to acid reflux
Squamous Cell Carcinoma
starts in the upper/middle esophagus, often linked to smoking and alcohol
Esophageal cancer is often diagnosed late because early symptoms are mild or mistaken for digestive problems.
Esophageal cancer begins in the esophagus, the long tube that carries food from the throat to the stomach.
The two main types are:
Adenocarcinoma
starts in the lower part of the esophagus, often linked to acid reflux
Squamous Cell Carcinoma
starts in the upper/middle esophagus, often linked to smoking and alcohol
Esophageal cancer is often diagnosed late because early symptoms are mild or mistaken for digestive problems.
1. Initial Detection / Screening
Common Symptoms:
Difficulty swallowing | dysphagia.
Painful swallowing | odynophagia.
Unintentional weight loss.
Chest pain or back pain.
Chronic cough or hoarseness.
Vomiting or regurgitation of food.
Bleeding | vomiting blood or black stools.
Risk Factors:
Long-term acid reflux | GERD | or Barrett’s esophagus.
Smoking and heavy alcohol use.
Obesity.
Diet low in fruits/vegetables.
Esophageal injury | from hot drinks or chemicals.
Screening:
No routine screening for the general population.
Endoscopic surveillance is recommended for patients with Barrett’s esophagus or other high-risk conditions.
Common Symptoms:
Difficulty swallowing | dysphagia.
Painful swallowing | odynophagia.
Unintentional weight loss.
Chest pain or back pain.
Chronic cough or hoarseness.
Vomiting or regurgitation of food.
Bleeding | vomiting blood or black stools.
Risk Factors:
Long-term acid reflux | GERD | or Barrett’s esophagus.
Smoking and heavy alcohol use.
Obesity.
Diet low in fruits/vegetables.
Esophageal injury | from hot drinks or chemicals.
Screening:
No routine screening for the general population.
Endoscopic surveillance is recommended for patients with Barrett’s esophagus or other high-risk conditions.
2. Diagnostic Tests
Upper Endoscopy - Esophagogastroduodenoscopy
Main diagnostic test.
A flexible tube with a camera is passed down the throat to view the esophagus.
Biopsy is taken from suspicious lesions for histopathology.
Barium Swallow - Esophagram
X-ray with barium contrast outlines the esophagus.
Shows irregular narrowing or obstruction, often used as an initial imaging tool.
Endoscopic Ultrasound
Determines depth of tumor invasion | T stage | and checks lymph node involvement.
CT Scan
Evaluates tumor spread to nearby organs and lymph nodes.
PET-CT Scan
Detects distant metastases.
Bronchoscopy
Used for upper or mid-esophageal tumors to check airway involvement.
Upper Endoscopy - Esophagogastroduodenoscopy
Main diagnostic test.
A flexible tube with a camera is passed down the throat to view the esophagus.
Biopsy is taken from suspicious lesions for histopathology.
Barium Swallow - Esophagram
X-ray with barium contrast outlines the esophagus.
Shows irregular narrowing or obstruction, often used as an initial imaging tool.
Endoscopic Ultrasound
Determines depth of tumor invasion | T stage | and checks lymph node involvement.
CT Scan
Evaluates tumor spread to nearby organs and lymph nodes.
PET-CT Scan
Detects distant metastases.
Bronchoscopy
Used for upper or mid-esophageal tumors to check airway involvement.
3. Pathology and Staging
Histological Types
Squamous cell carcinoma
Usually in upper or middle esophagus.
Linked to smoking and alcohol.
Adenocarcinoma
Usually in lower esophagus, near stomach.
Associated with Barrett’s esophagus and GERD.
Staging - TNM System
T – Depth of tumor invasion
N – Regional lymph node involvement
M – Distant metastasis
Grouped Stages:
Stage 0: Carcinoma in situ.
Stage I–II: Localized to esophagus wall ± nearby nodes.
Stage III: Locally advanced with multiple nodes or nearby structure invasion.
Stage IV: Distant metastasis.
Histological Types
Squamous cell carcinoma
Usually in upper or middle esophagus.
Linked to smoking and alcohol.
Adenocarcinoma
Usually in lower esophagus, near stomach.
Associated with Barrett’s esophagus and GERD.
Staging - TNM System
T – Depth of tumor invasion
N – Regional lymph node involvement
M – Distant metastasis
Grouped Stages:
Stage 0: Carcinoma in situ.
Stage I–II: Localized to esophagus wall ± nearby nodes.
Stage III: Locally advanced with multiple nodes or nearby structure invasion.
Stage IV: Distant metastasis.
4. Treatment Options
➛ Stage 0–I
Endoscopic therapy for small, superficial tumors
Endoscopic mucosal resection
Endoscopic submucosal dissection
Esophagectomy
for larger or deeper lesions.
➛ Stage II–III
Neoadjuvant Chemoradiation
Shrinks tumor and improves surgical success.
Typical regimen:
Carboplatin + Paclitaxel + Radiation | CROSS protocol.
Esophagectomy
Removes part or all of the esophagus and nearby lymph nodes.
Transhiatal esophagectomy:
through abdomen and neck.
Transthoracic esophagectomy:
through chest and abdomen.
Reconstructive surgery uses stomach or colon to replace removed esophagus.
Adjuvant Therapy
Chemotherapy or immunotherapy to reduce recurrence risk.
➛ Stage IV
Goal
palliative and life-prolonging treatment.
Systemic therapies
Chemotherapy:
Cisplatin + 5-FU, FOLFOX, or CAPOX regimens.
Targeted therapy:
HER2-positive ➧ trastuzumab.
VEGF-targeted ➧ ramucirumab.
Immunotherapy
PD-1 inhibitors for PD-L1 positive tumors.
Palliative radiation therapy
relieves swallowing difficulties or bleeding.
Esophageal stent placement
keeps esophagus open for swallowing.
➛ Stage 0–I
Endoscopic therapy for small, superficial tumors
Endoscopic mucosal resection
Endoscopic submucosal dissection
Esophagectomy
for larger or deeper lesions.
➛ Stage II–III
Neoadjuvant Chemoradiation
Shrinks tumor and improves surgical success.
Typical regimen:
Carboplatin + Paclitaxel + Radiation | CROSS protocol.
Esophagectomy
Removes part or all of the esophagus and nearby lymph nodes.
Transhiatal esophagectomy:
through abdomen and neck.
Transthoracic esophagectomy:
through chest and abdomen.
Reconstructive surgery uses stomach or colon to replace removed esophagus.
Adjuvant Therapy
Chemotherapy or immunotherapy to reduce recurrence risk.
➛ Stage IV
Goal
palliative and life-prolonging treatment.
Systemic therapies
Chemotherapy:
Cisplatin + 5-FU, FOLFOX, or CAPOX regimens.
Targeted therapy:
HER2-positive ➧ trastuzumab.
VEGF-targeted ➧ ramucirumab.
Immunotherapy
PD-1 inhibitors for PD-L1 positive tumors.
Palliative radiation therapy
relieves swallowing difficulties or bleeding.
Esophageal stent placement
keeps esophagus open for swallowing.
5. Post-Treatment and Follow-Up
Schedule
Every 3-6 months for 2 years, then every 6-12 months.
Imaging and endoscopy to monitor recurrence.
Nutritional & Supportive Care
Nutritional support | feeding tube or supplements | if swallowing is difficult.
Speech and swallowing therapy post-surgery.
Psychological support for quality of life.
Schedule
Every 3-6 months for 2 years, then every 6-12 months.
Imaging and endoscopy to monitor recurrence.
Nutritional & Supportive Care
Nutritional support | feeding tube or supplements | if swallowing is difficult.
Speech and swallowing therapy post-surgery.
Psychological support for quality of life.
Read More
➛ Step by Step Overview
➛ Patient's Appeal
➛ Patients’ Stories
➛ Transparency Page
➛ Volunteer / Partner Page